Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
about
Progress in genetic studies of pain and analgesiaSerum correlates of the placebo effect in irritable bowel syndromeThe role of genetics in IBS.An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered MicrobiomeGenes and environment in irritable bowel syndrome: one step forwardGenetic epidemiology of irritable bowel syndromeIrritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndromeCytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysisFood allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityBlastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, TurkeyPharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey.Current insights in to the pathophysiology of Irritable Bowel Syndrome.Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogeneticsTrauma history and risk of the irritable bowel syndrome in women veterans.Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel diseaseParasites in Mexican patients with irritable bowel syndrome: a case-control study.From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.A role for the gut microbiota in IBS.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis.S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Lessons Learnt from Post-Infectious IBS.Effects of Hypericum perforatum extract on rat irritable bowel syndrome.The immune system in irritable bowel syndromePathophysiologic findings of irritable bowel syndrome in china.Serum and colonic mucosal immune markers in irritable bowel syndromeEpidemiology of Functional Gastrointestinal Disorders in Japan and in the World.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsNew paradigm for studying genetic contributions to irritable bowel syndromeClinical impact of MMP and TIMP gene polymorphisms in gastric cancer.Probiotics in irritable bowel syndrome: an immunomodulatory strategy?Recent developments in the therapy of irritable bowel syndrome.High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.Genes and irritable bowel syndrome: is there a link?Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.Genetic approaches to functional gastrointestinal disorders.
P2860
Q24289028-F9F57160-5F74-4D24-8156-5C7FF92D4EBDQ24598909-2791FE84-2A3D-492E-95AB-45376C7CA259Q24600235-5DEC5314-09F3-4499-8438-E089A4674C95Q24630575-DD2CD376-49EA-4747-93D0-CCF52085C865Q24679798-3C6A5527-E09D-4E42-808C-0D51D8892E63Q26777392-703E22B9-E12A-4118-93F4-8C12232EF2E9Q26860280-9E4CE30A-1896-4396-A615-4D358A0A74B6Q27011652-C6CD8EEC-14FD-46DB-9DBE-84F4F76DAEDEQ28087731-62097271-9E18-4787-9DFD-FF228CA3B8CAQ28261163-DC32A29F-0169-4377-BF4E-3C5963C8029EQ33451900-9A6B657E-E990-4011-A842-643D17204B94Q33761372-C80E5FFD-4F92-40CB-90C5-5D6A9583D403Q33875272-3CF2C5C3-8B59-421E-A00C-67A9575E9DA4Q33890449-A49CF2EE-DACC-4ADE-A71D-34862F0447CEQ33992299-573E5A24-E6D2-41D7-9DE5-22BB431122B5Q34005405-AC6FBF17-EF73-40C9-8C12-FCEC7EE026EEQ34224754-3662861C-2AE0-465A-91C1-91F23BAB4894Q34243800-22D23DF0-86F6-4477-A8D3-8D9B26FC44A9Q34298260-ABAFF1CD-E761-4512-9A23-D7690FA06F1BQ34396950-769A49B0-8617-4342-9F59-860C1DFF4C91Q34409219-C0823FF6-53E4-4FAD-999B-7EC32C31DD4AQ34416297-C0C2436C-6410-492B-B781-9A4AF60CF9DEQ34626602-D34EC26C-2B1A-43A3-A8BB-2172E592A296Q34660809-6D7A6982-1DAA-40C3-A09E-C6BE3D8FC3E1Q34675807-EE60DE99-8457-4C3D-9A34-96107046A64BQ35176122-1F52A5B5-4062-43B3-BA73-9BB552B55572Q35215213-E185F0C4-1773-49E1-A193-53C4E9355BD2Q35587508-6CB3130B-46AC-4210-B6DA-EC0371EB74F3Q35730488-981A6DFD-5A24-40B2-8459-EEEA3BB714F6Q35815638-81E20185-C7E0-4F10-A0E1-9F93A9C2DE32Q35834528-3136B6DC-920E-4700-A715-B290E3457FB1Q36207200-29ECD678-6026-4DCD-9102-83EC5D4A7BAAQ36308871-BDA1D076-EEE7-460E-9895-5708ADD3CEA2Q36611620-9029C86F-F773-4344-AF2A-A2B9EE8335D3Q37054666-128287FD-CD4F-4DF6-9AAC-51D6FB9AE7E6Q37071175-33174C7A-17A9-4B09-A49C-2D719BCAEB72Q37108879-34C16E19-075E-4DE5-9187-2285A8FF5443Q37216842-818D35B5-DBDF-4111-9515-455758D5001CQ37234770-3A5153B0-B998-4E22-9AAE-DED1C8EB07BAQ37312059-BFA9000D-A460-40FD-8D91-4D3DEDC2CF42
P2860
Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Role of tumor necrosis factor- ...... s in irritable bowel syndrome.
@en
type
label
Role of tumor necrosis factor- ...... s in irritable bowel syndrome.
@en
prefLabel
Role of tumor necrosis factor- ...... s in irritable bowel syndrome.
@en
P2093
P2860
P1476
Role of tumor necrosis factor- ...... s in irritable bowel syndrome.
@en
P2093
Ad A M Masclee
Hein W Verspaget
Marlies van den Berg
Patrick P J van der Veek
Yvette E de Kroon
P2860
P304
P356
10.1111/J.1572-0241.2005.00257.X
P407
P577
2005-11-01T00:00:00Z